Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004

Neuro-Oncology

Volumn 12, Issue 7, 2010, Pages 725-735

  Bauchet, Luc ^a,c   Mathieu Daudé, Hélène ^c,d   Fabbro Peray, Pascale ^d   Rigau, Valérie ^b,c   Fabbro, Michel ^c   Chinot, Olivier ^e   Pallusseau, Loreleï ^c   Carnin, Charlotte ^c,d   Lainé, Karl ^c   Schlama, Aline ^g   Thiebaut, Agnes ^e   Patru, Maria Cristina ^h   Bauchet, Fabienne ^c   Lionnet, Martine ^a   Wager, Michel ⁱ   Faillot, Thierry ^j   Taillandier, Luc ^f   Figarella Branger, Dominique ⁿ   Capelle, Laurent ^k   Loiseau, Hugues ^m   Frappaz, Didier ^f   Campello, Chantal ^c   Kerr, Christine ^c   Duffau, Hugues ^l   Reme Saumon, Monique ^c   Trétarre, Brigitte ^d   Daures, Jean Pierre ^d   Henin, Dominique ^l   Labrousse, Français ^o,q,s   Menei, Philippe ^p,r   Honnorat, Jérome ^a,g   more..

^a INSERM   (France)

^b HÔPITAL SAINT ELOI   (France)

^c Department of Epidemiology   (France)

^d CENTRE VAL D AURELLE   (France)

^e UNIV MONTPELLIER   (France)

^f NÎMES UNIVERSITY HOSPITAL   (France)

^g TIMONE HOSPITAL   (France)

^h Hopital Neurologique   (France)

ⁱ UNIVERSITÉ LYON 1   (France)

^j HÔPITAL NEUROLOGIQUE   (France)

^k Department of Neurosurgery   (France)

^l POITIERS UNIVERSITY HOSPITAL   (France)

^m BEAUJON HOSPITAL   (France)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o CENTRE HOSPITALIER   (France)

^p HÔPITAL PELLEGRIN   (France)

^q CENTRE LÉON BÉRARD   (France)

^r LIMOGES UNIVERSITY HOSPITAL   (France)

^s ANGERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Database; Glioblastoma; Neuro oncology; Neurosurgery; Survival

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; PROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FRANCE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RESEARCH REPORT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650271417     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq030     Document Type: Article

References (55)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer Press; 2007.
2. McCarthy BJ, Surawicz T, Bruner JM, Kruchko C, Davis F. Consensus conference on brain tumor definition for registration, November 10, 2000. Neuro-Oncology. 2002;4:134-145.
3. McCarthy BJ, Kruchko C; Central Brain Tumor Registry of the United States. Consensus conference on cancer registration of brain and central nervous system tumors. Neuro-Oncology. 2005;7:196-201.
4. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology. 2002;4:278-299.
5. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492-507.
6. Central Brain Tumor Registry of the United States. (2008). Statistical report: primary brain tumors in the United States, 2000-2004. http://www.cbtrus.org/reports//2007-2008/2007report.pdf. Accessed June 1, 2008.
7. Bauchet L, Rigau V, Mathieu-Daudé H, et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol. 2007;84:189-199.
8. Wöhrer A, Waldhör T, Heinzl H, et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol. 2009;95:401-411.
9. Elia-Pasquet S, Provost D, Jaffré A, et al. Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology. 2004;23: 110-117.
10. Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003;99:467-473.
11. Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005;293:557-564. (Pubitemid 40171237)
12. Rosenthal MA, Drummond KJ, Dally M, et al. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust. 2006; 184:270-273.
13. Dally M, Rosenthal M, Drummond K, et al. Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study. J Med Imaging Radiat Oncol. 2009;53:318-324.
14. Magrini SM, Ricardi U, Santoni R, et al. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys. 2006;65:788-799.
15. Salmaggi A, Silvani A, Merli R, et al. Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience. Neurol Sci. 2008;29:77-83.
16. Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E. A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001;51:100-107.
17. Wrensch M, Rice T, Miike R, et al. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro-Oncology. 2006;8:12-26.
18. Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin S. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer. 2005;104:2798-2806.
19. Chang SM, Barker FG, 2nd. Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer. 2005;104:1975-1984.
20. Kita D, Ciernik IF, Vaccarella S, et al. Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology. 2009;33: 17-22.
21. Wiemels JL, Wilson D, Patil C, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009;125:680-687.
22. Barnholtz-Sloan JS, Williams VL, Maldonado JL, et al. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg. 2008;108:642-648.
23. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE. Patterns of care in elderly glioblastoma patients. Ann Neurol. 2008;64:628-634.
24. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology. 2003;5: 79-88.
25. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
26. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 2006;7: 392-401.
27. Bauchet L, Rigau V, Mathieu-Daudé H, et al. Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol. 2009;92:87-98.
28. Bauchet L, Mathieu-Daudé H, Rigau V, et al. Patterns of care for 952 patients with newly diagnosed glioblastoma [abstract]. J Clin Oncol. 2008;26(suppl 15):102S.
29. Kleihues P, Cavenee WK, eds. Tumours of the Nervous System, Pathology and Genetics Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press; 2000.
30. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(suppl 7):1953-1968.
31. Filippini G, Falcone C, Boiardi A, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro-Oncology. 2008;10:79-87.
32. Mirimanoff RO, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006;24:2563-2569.
33. Davis FG, Malmer BS, Aldape K, et al. Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2008;17:484-489.
34. Chérié-Challine L, Mouquet MC, Marescaux C. Incidence et traitement chirurgical des cancers. Revue de la DREES no 199-Octobre 2002, 1-12. http://www.santeg,ouv.fr/drees/etude-resultat/er-pdf/er199.pdf. Accessed November 12, 2002.
35. Barker FG, 2nd, Curry WT, Jr, Carter BS. Surgery for primary supratentorial brain tumors in theUnited States, 1988to2000: the effect of provider caseload and centralization of care. Neuro-Oncology. 2005;7:49-63.
36. Mineo JF, Bordron A, Baroncini M, et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien). 2007;149:245-252.
37. Barker FG, 2nd, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998;42:709-720.
38. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459-466.
39. Menei P, Capelle L, Guyotat J, et al. Local and sustained delivery of 5- fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery. 2005;56:242-248.
40. Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapyshortens survival in patients with high grade glioma. J Neurooncol. 2007;85:339-343.
41. Pirzkall A, McGue C, Saraswathy S, et al. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology. 2009;11:842-852.
42. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980;303:1323-1329.
43. Cher L, Rosenthal MA, Drummond KJ, et al. The use of chemotherapy in patients with gliomas: patterns of care in Victoria from 1998-2000. J Clin Neurosci. 2008;15:398-401.
44. van Genugten JA, Leffers P, Baumert BG, Tjon-A-Fat H, Twijnstra A. Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. J Neurooncol. 2010;96:249-257.
45. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20:1375-1382.
46. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-Oncology. 2004;6:227-235.
47. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg. 1993;78:767-775.
48. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-198.
49. Stummer W, Kamp MA. The importance of surgical resection in malignant glioma [published online ahead of print September 04, 2009]. Curr Opin Neurol.
50. Pichlmeier U, Bink A, Schackert G, Stummer W; ALA Glioma Study Group. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro-Oncology. 2008;10:1025-1034.
51. Gorlia T, van den Bent MJ, Hegi ME, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol. 2008;9:29-38.
52. Laperriere N, Zuraw L, Cairncross G; Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol. 2002;64:259-273.
53. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527-1535.
54. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011-1018.
55. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585-2597.